2024-03712. Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc.
-
Start Preamble
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Siemens Healthcare Diagnostics Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 23, 2024. Such persons may also file a written request for a hearing on the application on or before April 23, 2024.
ADDRESSES:
The Drug Enforcement Administration (DEA) requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on January 10, 2024, Siemens Healthcare Diagnostics Inc., 100 GBC Drive, Mailstop 108, Newark, Delaware 19702–2461 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Start Printed Page 13745
Controlled substance Drug code Schedule Ecgonine 9180 II The company plans to produce the listed controlled substance in bulk to be used in the manufacture of the DEA exempt products. No other activities for this drug code is authorized for this registration.
Start SignatureMarsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–03712 Filed 2–22–24; 8:45 am]
BILLING CODE P
Document Information
- Published:
- 02/23/2024
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2024-03712
- Dates:
- Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 23, 2024. Such persons may also file a written request for a hearing on the application on or before April 23, 2024.
- Pages:
- 13744-13745 (2 pages)
- Docket Numbers:
- Docket No. DEA-1322
- PDF File:
- 2024-03712.pdf